Arcturus Therapeutics Holdings Inc. (ARCT)

Arcturus Therapeutics Holdings Inc. (ARCT) is a healthcare company (biotechnology) based in the United States. The share price is $7.91, down 4.77% on the day, which values the company at $228.09M. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$7.91−4.77% today
Market value
$228.09M
Funk Score
36/100
Against its own history
Well below its usual priceusual price $11.49
200-week average
$18.7158% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Arcturus Therapeutics Holdings Inc. in more detail

ARCT trades at -2.4× next year's expected earnings, 7.5× sales. Measured against its own history, the price is 31% below what its usual multiples would imply ($11.49) — well below its usual price. It sits 58% below its 200-week average of $18.71.

Over the last five fiscal years Arcturus Therapeutics Holdings Inc. has compounded revenue 47.8% a year. Its Funk Score is 36 out of 100 (financial strength 2.8, profitability 2.3, growth 4.7, value 4.5, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

1 of the superinvestors tracked here hold ARCT, including Cathie Wood (0.2% of the portfolio).

Superinvestors holding ARCT

1 of the investors tracked here report a position in their latest 13F filing.

Arcturus Therapeutics Holdings Inc. (ARCT): questions and answers

What is Arcturus Therapeutics Holdings Inc.'s market cap?

Arcturus Therapeutics Holdings Inc. is valued at $228.09M at a share price of $7.91.

Is ARCT overvalued or undervalued?

Against its own history, ARCT is well below its usual price: the price is 31% below the $11.49 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ARCT above its 200-week moving average?

No. ARCT is 57.7% below its 200-week average of $18.71. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Arcturus Therapeutics Holdings Inc. growing?

Over the last five fiscal years Arcturus Therapeutics Holdings Inc.'s revenue grew 47.8% a year.

Does ARCT pay a dividend?

Arcturus Therapeutics Holdings Inc. does not currently pay a regular dividend.

Which famous investors own ARCT?

In their latest quarterly filings, Cathie Wood (0.2% of the portfolio) hold ARCT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Arcturus Therapeutics Holdings Inc. (ARCT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ARCT

Underlying data: Yahoo Finance; company filings with the SEC.